This is an interesting talk that argues for a personalized approach to acute stroke management, e.g. your trial result does not equal my patient! 

Particularly interesting at 11.50 is the compelling argument for prediction of individualized bleeding, which PBS hopes to deliver with its RapidResponse cellular fibronectin assay.